Role of coagulation factor XIII in cardio- and cerebrovascular diseases;Die rolle von faktor XIII bei kardio- und zerebrovaskulären erkrankungen

Hamostaseologie

Volumn 22, Issue 1, 2002, Pages 39-44

  Kohler, H P ^a   Schroder V ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Factor XIII; FXIII Val34Leu polymorphism; Insulin resistance syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 13; INSULIN; THROMBIN;

ATHEROMATOSIS; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CROSS LINKING; DEEP VEIN THROMBOSIS; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; HEART DISEASE; HEART INFARCTION; HEREDITY; INSULIN RESISTANCE; LUNG EMBOLISM; REVIEW; RISK FACTOR;

EID: 0036190517     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622007     Document Type: Review

References (56)

1. Tissue transglutaminase and factor XIII in cartilage and bone remodeling
2. The FXIII Val34Leu mutation and the risk of venous thrombosis
3. Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity
4. Molecular basis of inherited factor XIII deficiency: Identification of multiple mutations provides insights into protein function
5. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension
6. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
7. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism
8. Effect of the FXIII Val34Leu polymorphism on the interaction between platelets and cross-linked fibrin
9. Val34Leu polymorphism of plasma factor XIII: Biochemistry and epidemiology in familial thrombophilia
10. Zur frage der reversibilität der fibringerinnung
11. Genetic polymorphisms and coronary artery disease in the south of France
12. The association of the α-fibrinogen Thr312Ala polymorphismus with post-stroke mortality in subjects with atrial fibrillation
13. α-fibrinogen Thr312Ala polymorphism and venous thromboembolism
14. Factor XIII Val34Leu: A novel association with primary intracerebral hemorrhage
15. Association of a common polymorphism in the factor XIII gene with venous thrombosis
16. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism
17. Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage
18. The genetics of haemostasis: A twin study
19. Pathogenesis of primary pulmonary embolism: Impact of the FXIIIVal34Leu polymorphism
20. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction
21. Factor V is a substrate for the transamidase factor XIIIa
22. Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers
23. Factor XIII Val34Leu and the risk of myocardial infarction
24. Factor XIIIVal34Leu is a genetic factor involved in the aetiology of venous thrombosis
25. A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases
26. Transglutaminases: Multifunctional crosslinking enzymes that stabilize tissue
27. The Val34Leu polymorphism in the A-subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity
28. 2-plasmin inhibitor
29. A common coding polymorphism in the factor XIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity
30. Factor XIII activity and antigen levels in patients with coronary artery disease. Interaction with FXIIIVal34Leu
31. Levels of activated factor XII in survivors of myocardial infarction. Association with circulating risk factors and extent of coronary artery disease
32. Prevalence of three common polymorphisms in the A-subunit gene of FXIII in patients with coronary artery disease. Association with FXIII activity and antigen levels
33. FXII (46C(T) polymorphism and in vivo generation of FXII activity
34. Clustering of FXIIIVal34Leu with haemostatic risk factors
35. Plasminogen activator inhibitor type 1 and coronary artery disease
36. Interaction between insulin resistance and factor XIIIVal34Leu in patients with coronary artery disease
37. Association of a common polymorphism in the factor XIII gene with myocardial infarction
38. Fibrin clots. Some properties of the "serum factor"
39. Titration of the acceptor cross-linking sites in fibrin
40. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and their firstdegree relatives
41. Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis
42. Prevalence of FXIIIV34L in populations with different cardiovascular risk
43. Deficiency in the A-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels
44. Factor XIIIV34L is not an additional genetic risk factor for venous thrombosis in factor V Leiden carriers
45. Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa
46. Role of insulin resistance in human disease
47. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria
48. Interaction of the factor XIII activation peptide with α-thrombin
49. Racial and genetic determinants of plasma factor XIII activity
50. 2-antiplasmin incorporation into fibrin
51. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin
52. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene
53. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIIIVal34Leu mutation
54. Human procarboxypeptidase U, or thrombin-activatable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin
55. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
56. B protein of factor XIII: Differentiation between free B and complexed B